Page last updated: 2024-08-17

cycloheximide and Vascular Malformations

cycloheximide has been researched along with Vascular Malformations in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gao, YJ; Ge, ZZ; Liang, Q; Lin, XL; Tang, CT; Tang, MY; Wu, S; Zhang, QW1

Other Studies

1 other study(ies) available for cycloheximide and Vascular Malformations

ArticleYear
Thalidomide targets EGFL6 to inhibit EGFL6/PAX6 axis-driven angiogenesis in small bowel vascular malformation.
    Cellular and molecular life sciences : CMLS, 2020, Volume: 77, Issue:24

    Topics: Angiogenesis Inhibitors; Animals; Calcium-Binding Proteins; Cell Adhesion Molecules; Cycloheximide; Disease Models, Animal; Endothelial Cells; Gastrointestinal Tract; Gene Expression Regulation; Hemorrhage; Humans; Intestine, Small; Morphogenesis; Neovascularization, Pathologic; Peptide Hydrolases; Thalidomide; Vascular Malformations; Zebrafish; Zebrafish Proteins

2020